Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsalva vs Dexmedetomidine for Propofol Injection Pain
NCT05225610Completed
- Sponsor
- Tanta University
- Start
- Feb 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in pain (3 arms), sponsored by Tanta University. Primary endpoint: Pain Assessment. Started Feb 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05225610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05225610.